SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 309 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $5,000 | -16.7% | 30 | -45.5% | 0.00% | -20.0% |
| Q4 2014 | $6,000 | -99.8% | 55 | -99.7% | 0.01% | -99.8% |
| Q3 2014 | $2,615,000 | +7.9% | 16,736 | -14.8% | 2.16% | +10.6% |
| Q2 2014 | $2,423,000 | +60475.0% | 19,646 | +54472.2% | 1.95% | +64833.3% |
| Q1 2014 | $4,000 | 0.0% | 36 | -26.5% | 0.00% | 0.0% |
| Q4 2013 | $4,000 | +33.3% | 49 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $3,000 | – | 49 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
| OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
| SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
| Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
| Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
| HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
| CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
| Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |